Men with inflammatory bowel disease have four to five times higher risk of being diagnosed with prostate cancer, according to a 20-year study from Northwestern Medicine published in the journal European Urology.

Shilajit Kundu, MD, chief of Urologic Oncology and a member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University discusses the link between prostate cancer and inflammatory bowel disease. He shares Northwestern Medicine's approach to screening, diagnosing and treating this unique combination of conditions.